Optimizing Gastroenterology Express Scripts Integration for Prior Authorization

Gastroenterology practices face unique prior authorization complexities, particularly when navigating pharmacy benefit managers like Express Scripts for high-cost biologic medications and specialty drugs. Klivira streamlines gastroenterology Express Scripts integration to accelerate approvals and reduce administrative overhead.

Revenue cycle leaders and prior authorization coordinators in gastroenterology understand the critical need for efficient PA workflows. The intersection of complex GI treatment protocols and stringent PBM requirements, such as those from Express Scripts (an Evernorth pharmacy), often leads to delays and denials. Klivira provides a robust solution to automate and optimize these critical processes.

Navigating Express Scripts PA for High-Volume GI Therapies

Gastroenterology PA is characterized by a high volume of biologics for conditions like Crohn's disease and ulcerative colitis, alongside specialized procedures and imaging. Express Scripts, as a major PBM, enforces specific criteria for these treatments. Klivira’s platform is engineered to address these demands, ensuring that requests for drugs such as Humira, Stelara, Skyrizi, or Entyvio align with Express Scripts' policy requirements from the initial submission.

Key Gastroenterology PA Triggers Requiring Express Scripts Scrutiny

IBD Biologics: TNF inhibitors (e.g., adalimumab, infliximab), integrin inhibitors (vedolizumab), IL-12/23 inhibitors (ustekinumab), JAK inhibitors (tofacitinib, upadacitinib), S1P modulators (ozanimod, etrasimod), and risankizumab.
Hepatitis C Direct-Acting Antivirals: Sofosbuvir-velpatasvir (Epclusa) and glecaprevir-pibrentasvir (Mavyret), with specific pathways for treatment-naive vs. treatment-experienced patients.
Advanced Imaging: MRCP, MR enterography, CT enterography for IBD assessment, often requiring detailed clinical justification.
Endoscopic Procedures: Capsule endoscopy (CPT 91110), small-bowel enteroscopy, ERCP, and EUS for specific diagnostic or therapeutic indications.
Specialty Drugs for Functional GI Disorders: Eluxadoline (Viberzi), prucalopride (Motegrity), linaclotide (Linzess), and plecanatide (Trulance).

Meeting Documentation Standards for Express Scripts GI Approvals

Successful prior authorization with Express Scripts for gastroenterology treatments hinges on meticulous documentation. Payers commonly reference guidelines from ACG, AGA, and AASLD. Klivira's integration with your EMR automates the extraction of crucial data points, including diagnosis confirmation, disease severity assessments (Mayo score, CDAI), prior conventional therapy trials (e.g., 5-ASA, immunomodulators), TB and hepatitis screening status, and fibrosis stage for Hep C DAAs, ensuring comprehensive submissions.

Common Express Scripts Denial Reasons in GI and Klivira's Mitigation

Step therapy non-compliance for IBD biologics (e.g., requiring conventional therapy trial or TNF inhibitor before non-TNF agents).
Mandated biosimilar substitution for brand TNF inhibitors.
Inadequate documentation of disease severity (missing Mayo score, CDAi) or screening (TB, hepatitis).
Fibrosis-stage documentation gaps or misclassification of Hep C DAA treatment status.
Lack of clinical correlation or insufficient prior workup for advanced imaging and capsule endoscopy requests.

Klivira's Strategic Approach to Gastroenterology PBM Workflows

Klivira's platform integrates seamlessly with your EMR to provide a tailored solution for gastroenterology Express Scripts integration. We automate the periodic re-authorization workflow for chronic IBD biologics, a significant burden in GI. Our system intelligently classifies treatment status (naive vs. experienced) for biologics and Hep C DAAs, and adeptly manages the medical-vs-pharmacy benefit split for biologic agents, routing requests appropriately based on administration mode.

Leveraging Klivira for Enhanced Payer Connectivity

Beyond Express Scripts, Klivira offers broad connectivity across various payer portals and channels. Our solution is designed to handle the nuances of GI prior authorization, from complex biologic step therapies to specific procedural requirements. By automating the submission process and providing real-time status updates, Klivira enables gastroenterology practices to reduce manual tasks, improve turnaround times, and focus more on patient care rather than administrative hurdles.

Frequently asked questions

How does Klivira handle Express Scripts' step therapy requirements for IBD biologics?

Klivira's platform incorporates ACG/AGA-guideline-aware logic to automate the assessment of step therapy compliance for IBD biologics. This ensures that prior authorization requests submitted to PBMs like Express Scripts meet their specific criteria for conventional therapy trials or biosimilar preferences, reducing manual review and denial risks.

Can Klivira differentiate between medical and pharmacy benefit PA for GI biologics with Express Scripts?

Yes, Klivira's system is designed to intelligently route prior authorization requests based on whether a biologic agent is administered under the medical or pharmacy benefit. This is crucial for GI practices, as many IBD biologics can switch benefit sides depending on the administration mode, ensuring correct submission to Express Scripts.

What EMR data does Klivira use for gastroenterology Express Scripts integration?

Klivira integrates with your EMR to extract relevant clinical data for GI PA, including diagnosis codes, medication history, lab results (e.g., TB/hepatitis screening, genotype, fibrosis stage), disease activity scores (Mayo score, CDAI), and prior treatment details. This comprehensive data populates PA forms for Express Scripts, minimizing manual data entry.

How does Klivira manage recurring prior authorizations for chronic GI conditions?

For chronic GI conditions requiring ongoing biologic therapy, such as IBD, Klivira automates the periodic re-authorization workflow. Our system tracks re-authorization dates and prompts for necessary documentation updates, ensuring timely resubmissions to Express Scripts and preventing treatment interruptions due to expired approvals.

Does Klivira support PA for advanced GI imaging and endoscopic procedures with Express Scripts?

Yes, Klivira supports prior authorization for advanced GI imaging (e.g., MRCP, CT enterography) and endoscopic procedures (e.g., capsule endoscopy). Our platform helps ensure that the clinical justification and prior workup documentation required by Express Scripts for these services are complete and accurately submitted.